CTA
IDXX icon

Carillon Tower Advisers’s Idexx Laboratories IDXX Stock Holding History

Carillon Tower Advisers’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		$141M Buy
282,556
+267,606
+1,790% +$120M 0.86% 15
2020
Q3 		$5.88M Sell
14,950
-267,556
-95% -$98.9M 0.08% 314
2020
Q2 		$93.3M Hold
282,506
– – 0.72% 30
2020
Q1 		$65.3M Buy
282,506
+14,900
+6% +$3.89M 0.64% 38
2019
Q4 		$69.9M Sell
267,606
-38,925
-13% -$10.3M 0.47% 62
2019
Q3 		$83.3M Buy
306,531
+38,925
+15% +$10.8M 0.58% 33
2019
Q2 		$73.7M Hold
267,606
– – 0.51% 49
2019
Q1 		$59.8M Sell
267,606
-87,255
-25% -$18M 0.42% 72
2018
Q4 		$66M Buy
354,861
+25,621
+8% +$5.25M 0.56% 39
2018
Q3 		$82.2M Buy
329,240
+57,982
+21% +$14.1M 0.59% 30
2018
Q2 		$59.1M Sell
271,258
-16,601
-6% -$3.42M 0.47% 60
2018
Q1 		$53.7M Buy
287,859
+39,473
+16% +$7.29M 0.42% 66
2017
Q4 		$38.8M Buy
+248,386
New +$39.1M 0.41% 83

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $13.6B AUM 7.6% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $38.4B AUM 25.71% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

Carillon Tower Advisers's IDXX Position: Q4 2020 in Review

Carillon Tower Advisers increased its Idexx Laboratories (IDXX) stake by 1,790% in Q4 2020, buying an estimated $120M and bringing the position to 282,556 shares worth $141M. The position accounts for 0.86% of the portfolio, ranked #15.

Carillon Tower Advisers first reported a position in IDXX in Q4 2017 and has held it in 13 quarters since. 972 funds tracked by Wall St. Rank hold IDXX as of Q4 2020.

  • Carillon Tower Advisers held 282,556 shares of Idexx Laboratories worth $141M as of Q4 2020.
  • Carillon Tower Advisers bought 267,606 Idexx Laboratories shares in Q4 2020, an estimated $120M.
  • Idexx Laboratories made up 0.86% of Carillon Tower Advisers's portfolio in Q4 2020, its #15 holding.
  • Carillon Tower Advisers first reported a position in Idexx Laboratories in Q4 2017 and has held it in 13 quarters since.
  • 972 funds tracked by Wall St. Rank held Idexx Laboratories as of Q4 2020.

Based on Carillon Tower Advisers's 13F filing for Q4 2020, filed 12 Feb 2021.